510(k) K770455

GLUCOSE PROCEDURE, TEKPOINT DIRECT by Icn Pharmaceuticals, Inc. — Product Code CGE

K770455 is an FDA 510(k) premarket notification submitted by Icn Pharmaceuticals, Inc. for the device "GLUCOSE PROCEDURE, TEKPOINT DIRECT". The FDA issued a decision of Substantially Equivalent on May 3, 1977. The device falls under product code CGE (Orthotoluidine, Glucose), a Class II device regulated under 21 CFR 862.1345. Icn Pharmaceuticals, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 3, 1977
Date Received
March 8, 1977
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Orthotoluidine, Glucose
Device Class
Class II
Regulation Number
862.1345
Review Panel
CH
Submission Type